Share Name Share Symbol Market Type Share ISIN Share Description
Deepmatter Group Plc LSE:DMTR London Ordinary Share GB00B29YYY86 ORD 0.01P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.0% 1.925 1.90 1.95 1.925 1.925 1.925 223,749 08:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Chemicals 1.3 -2.7 -0.3 - 18

DeepMatter Group PLC Agreement with Merck's Life Sciences business

20/01/2021 7:00am

UK Regulatory (RNS & others)

Deepmatter (LSE:DMTR)
Historical Stock Chart

From Dec 2020 to Jun 2021

Click Here for more Deepmatter Charts.


RNS Number : 2326M

DeepMatter Group PLC

20 January 2021

20 January 2021

DeepMatter Group plc

("DeepMatter", the "Company" or "the Group")

DeepMatter subsidiary signs data licensing agreement with the Life Science business of Merck

DeepMatter Group plc, the AIM-quoted company focusing on digitising chemistry, is pleased to announce that one of its wholly owned subsidiaries has entered into a multi-year, limited-use data licensing agreement with the Life Science business of Merck to provide proprietary chemical structure and reaction data content to Merck's selected application.

Merck, a leading science and technology company, operates across Healthcare, Life Science and Performance Materials. The terms of the data license agreement have not been disclosed.

Mark Warne, CEO of DeepMatter commented : "We are delighted to have entered into this license with Merck, a company dedicated to making research and biotech simpler, faster and safer."

For more information, please contact:

 DeepMatter Group plc                        T: 0141 548 8156 
 Mark Warne, Chief Executive Officer 
   Canaccord Genuity Limited (Nominated        T: 020 7523 8000 
   Advisor and Broker) 
 Bobbie Hilliam / Angelos Vlatakis 
 Alma PR                                     T: 020 3405 0205 
 Caroline Forde / Harriet Jackson / Kieran 

About DeepMatter Group plc

DeepMatter's long term strategy is to integrate chemistry with technology, thereby enabling a greater use of artificial intelligence and reaching a point where chemicals can be autonomously synthesised through robotics. It has developed and is commercialising data rich platform technologies, including software and laboratory hardware, focused on applications to improve R&D productivity and discovery using Machine Learning / Artificial Intelligence.

DeepMatter's technologies allow chemistry experiments to be accurately and systematically recorded, coded and entered into a shared data cloud. They are designed to enable chemists to work together effectively; sharing the details of their experiments from anywhere and in real-time, so that work is not needlessly duplicated, time and money wasted, and ultimately so new discoveries may be made faster.

About Merck

Merck, a leading science and technology company, operates across Healthcare, Life Science and Performance Materials. Around 57,000 employees work to make a positive difference to millions of people's lives every day by creating more joyful and sustainable ways to live. From advancing gene editing technologies and discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices - the company is everywhere. In 2019, Merck generated sales of EUR16.2 billion in 66 countries.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.



(END) Dow Jones Newswires

January 20, 2021 02:00 ET (07:00 GMT)

1 Year Deepmatter Chart

1 Year Deepmatter Chart

1 Month Deepmatter Chart

1 Month Deepmatter Chart
ADVFN Advertorial
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20210614 02:21:18